This prohibition shall extend to any form of direct or indirect promotional activity in print, electronic, digital, social media, or any other public platform that is intended, directly or indirectly, ...

India's CDSCO has warned pharma firms against promoting prescription weight-loss drugs (GLP-1s) via surrogate or digital ads, ...

The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for presc ...

Prepare the ass kissing to begin! With a new CFO, Monks' employees will look to be buddy buddy with the person who approves ...

Major OTAs spent over $20 billion on marketing in 2025 as competition intensifies and platforms battle to win travelers.

By Rishika Sadam March 11 (Reuters) - India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns ...

Fourth quarter results reflect meaningful progress in transformation journey Ian Bickley appointed Chairman and Chief ...

The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers and marketing authorisation holders to ensure strict compliance with ...

As blockbuster weight-loss drugs surge in India, regulators warn that "awareness campaigns" may be blurring the line between public health messaging and pharmaceutical marketing.

The conventional model assumes retail follows office growth and major employer recruitment — when in reality, it often makes ...

Direct impact of 10% increase in oil prices estimated to be around almost 1% on WPI: Bank of Baroda ...